Clinical Trial Update: Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This terminated Phase 1/Phase 2 trial studied salvage therapy combining chemotherapy and natural killer (NK) cell therapy for relapsed or refractory pediatric T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Chemotherapy (unspecified)
• Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Conditions: Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma | Phase 1, Phase 2 | Status: TERMINATED